Tod M. Woolf
52Patents
20h-index
36Co-inventors
88Inventor score
Filing activity: Nov 4, 1994 → May 12, 2020
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US5849902A | Three component chimeric antisense oligonucleotides | Chemistry; Metallurgy | 242 | Expired |
| US6673611B2 | Nucleic acid molecules with novel chemical compositions capable of modulating gene expression | Chemistry; Metallurgy | 103 | Expired |
| US8796443B2 | Reduced size self-delivering RNAi compounds | Chemistry; Metallurgy | 86 | Active |
| US9175289B2 | Reduced size self-delivering RNAi compounds | Chemistry; Metallurgy | 70 | Active |
| US5989912A | Three component chimeric antisense oligonucleotides | Chemistry; Metallurgy | 59 | Expired |
| US9080171B2 | Reduced size self-delivering RNAi compounds | Chemistry; Metallurgy | 53 | Active |
| US8815818B2 | Phagocytic cell delivery of RNAI | Chemistry; Metallurgy | 52 | Active |
| US8664189B2 | RNA interference in skin indications | Chemistry; Metallurgy | 51 | Active |
| US9095504B2 | RNA interference in ocular indications | Chemistry; Metallurgy | 47 | Active |
| US9074211B2 | Inhibition of MAP4K4 through RNAI | Chemistry; Metallurgy | 47 | Active |
| US9340786B2 | RNA interference in dermal and fibrotic indications | Chemistry; Metallurgy | 46 | Active |
| US9303259B2 | RNA interference in skin indications | Chemistry; Metallurgy | 44 | Active |
| US9745574B2 | RNA duplexes with single stranded phosphorothioate nucleotide regions for additional functionality | Chemistry; Metallurgy | 40 | Active |
| USD568753S1 | Bottle | General | 33 | Expired |
| US10479992B2 | RNA duplexes with single stranded phosphorothioate nucleotide regions for additional functionality | Chemistry; Metallurgy | 25 | Active |
| US9938530B2 | RNA interference in skin indications | Chemistry; Metallurgy | 23 | Active |
| US5693532A | Respiratory syncytial virus ribozymes | Chemistry; Metallurgy | 23 | Expired |
| US10041073B2 | Reduced size self-delivering RNAi compounds | Chemistry; Metallurgy | 21 | Active |
| US10131904B2 | Modified RNAi polynucleotides and uses thereof | Chemistry; Metallurgy | 21 | Active |
| US9963702B2 | RNA interference in dermal and fibrotic indications | Chemistry; Metallurgy | 20 | Active |
| US10240149B2 | Reduced size self-delivering RNAi compounds | Chemistry; Metallurgy | 19 | Active |
| US10138485B2 | Neutral nanotransporters | Chemistry; Metallurgy | 19 | Active |
| US10633654B2 | Modified RNAi polynucleotides and uses thereof | Chemistry; Metallurgy | 18 | Active |
| US10184124B2 | RNA interference in ocular indications | Chemistry; Metallurgy | 18 | Active |
| US10662430B2 | RNA interference in ocular indications | Chemistry; Metallurgy | 13 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.